Examination of Several Potential Mechanisms for the Negative Outcome in a Clinical Stroke Trial of Enlimomab, a Murine Anti-Human Intercellular Adhesion Molecule-1 Antibody: A Bedside-to-Bench Study (Q31028414)
scientific article published on November 1, 2001
Language:
(P31) (Q13442814)
(P50) (Q124791694)
(P304) 2665-2674
(P407) (Q1860)
(P433) 11
(P478) 32
(P577) Thursday, November 1, 2001
Thursday, November 1, 2001
(P921) (Q79460)
(P953) https://www.ahajournals.org/doi/pdf/10.1161/hs3211.098535
http://journals.lww.com/00007670-200111000-00034
(P1433) (Q7624282)
(P1476) "Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study" (language: en)
"Examination of Several Potential Mechanisms for the Negative Outcome in a Clinical Stroke Trial of Enlimomab, a Murine Anti-Human Intercellular Adhesion Molecule-1 Antibody: A Bedside-to-Bench Study" (language: en)
(P2093) K. Furuya
H. Takeda
S. Azhar
R. M. McCarron
Y. Chen
C. A. Ruetzler
K. M. Wolcott
R. Rothlein
T. E. Hugli
G. J. del Zoppo
J. M. Hallenbeck
other details
description scientific article published on November 1, 2001

External Links